Ultrasound to track baby heart function in heart disease
Part of Genetic & congenital, Heart & circulation clinical trials.
This study uses automated ultrasound measurements to track how a baby’s heart is working during pregnancy. It compares babies who have a specific congenital heart problem with babies without it, to understand what ultrasound can detect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your pregnancy is a single baby (not twins or more).
- You are between 19 weeks 6 days and 36 weeks 6 days pregnant (exact window depends on group).
- If you are in the heart-disease group: your baby has an isolated congenital heart (heart) anomaly.
- If you are in the control group: your baby has no congenital heart anomaly.
- You do not have certain pregnancy conditions that can affect the baby’s heart function (like diabetes, preeclampsia, or cholestasis).
- No other major birth defects or known genetic conditions were found.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study records newborn heart measurements (using medical imaging) to compare babies with certain congenital heart defects to healthy-term babies. The goal is to see how well one test matches another, which may help doctors better understand heart conditions in newborns.
This study uses a special ultrasound method (speckle tracking echocardiography) to measure heart function in newborns, including those born early, at term, or with certain health conditions like lung problems or lack of oxygen at birth.
This study uses non-invasive devices to monitor the hearts of pregnant women and their babies. It compares women with and without heart conditions, and babies with normal hearts or heart concerns, to see if early warning signs of cardiac problems can be detected.
This study tests an artificial intelligence (AI) tool to help doctors spot heart problems in unborn babies during pregnancy. If you are between 16 and 40 weeks pregnant and your baby's heart ultrasound images are clear, this trial may help improve how heart issues are found early.
This study tests a new, faster ultrasound technique to see heart structure and blood flow in children with or without congenital heart disease (CHD). It aims to improve imaging without risk, using a short scan during a regular check-up.
This study looks at the link between preeclampsia (a pregnancy complication with high blood pressure) and a mother's heart health when her baby has a heart problem. The goal is to understand how the mother's heart adapts during pregnancy in these cases.
Hear when a new Cardiac Function trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.